Biaryl heterocycle substituted oxazolidinone antibacterial agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9359344
APP PUB NO 20140235584A1
SERIAL NO

14347583

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a biaryl heterocycle substituted oxazolidinone antibacterials shown by general formula (I), a pharmaceutically acceptable salt thereof, an isomer or a prodrug thereof, wherein R1, R2, R3, R4, R5, A and B are as defined in the description. The present invention further relates to a method for preparing the compound, a pharmaceutical composition and a pharmaceutical formulation comprising the compound, and a use of the compound in the manufacture of a medicament for the treatment and/or prevention of infectious diseases and a use for the treatment and/or prevention of infectious diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XUANZHU PHARMA CO LTD2518 TIANCHEN STREET NATIONAL HIGH-TECH DEVELOPMENT ZONE JINAN-CITY SHANDONG PROVINCE 250101

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wang, Aichen Shandong, CN 10 18
Wu, Frank Shandong, CN 101 2813

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00